ClinicalTrials.Veeva

Menu

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

G

Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)

Status

Unknown

Conditions

Chronic Kidney Failure

Treatments

Other: Hemodiafiltration
Other: High-flux hemodialysis

Study type

Interventional

Funder types

Other

Identifiers

NCT03456232
GDREC2017324H

Details and patient eligibility

About

This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.

Full description

Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy.

Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Subject has end-stage renal disease.
  2. Subject has been on regular dialysis treatment for at least 6 months.
  3. Subject has autologous vascular access.
  4. Subject is offered thrice weekly hemodialysis.
  5. Subject is offered 4 hours duration hemodialysis.

Exclusion criteria

  1. Infectious disease
  2. Poor echocardiographic window that was unsuitable for interpretation

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

High-flux hemodialysis
Experimental group
Description:
High-flux hemodialysis lasting for 4 hours
Treatment:
Other: High-flux hemodialysis
Hemodiafiltration
Active Comparator group
Description:
Hemodiafiltration lasting for 4 hours
Treatment:
Other: Hemodiafiltration

Trial contacts and locations

1

Loading...

Central trial contact

Yi Li, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems